Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
RATIONALE: Drugs used in chemotherapy, such as epirubicin, oxaliplatin, fluorouracil, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving chemotherapy and radiation therapy after surgery may kill any tumor cells that remain after surgery.
PURPOSE: This phase II trial is studying how well giving combination chemotherapy, surgery, and radiation therapy works in treating patients with locoregionally advanced cancer of the esophagus, gastroesophageal junction, or stomach.
Full description
OBJECTIVES:
Primary
Secondary
OUTLINE:
After completion of study treatment, patients are followed every 8-12 weeks for 3 years.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
61 participants in 1 patient group
There are currently no registered sites for this trial.
Start date
Jan 05, 2008 • 17 years ago
End date
Mar 26, 2012 • 12 years ago
Results posted
ViewApr 19, 2019 • 5 years ago
Today
Jan 20, 2025
Lead Sponsor
Collaborating Sponsor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal